Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6U49

Structure-based discovery of a novel small-molecule inhibitor of methicillin-resistant S. aureus

Summary for 6U49
Entry DOI10.2210/pdb6u49/pdb
Related6U3T
DescriptorAlpha-hemolysin, fos-choline-14, SULFATE ION, ... (4 entities in total)
Functional Keywordsalpha-toxin, pvl, leukocidins, mrsa, toxin
Biological sourceStaphylococcus aureus
Total number of polymer chains7
Total formula weight241501.30
Authors
Liu, J.,Kozhaya, L.,Torres, V.J.,Unutmaz, D.,Lu, M. (deposition date: 2019-08-23, release date: 2020-03-25, Last modification date: 2023-10-11)
Primary citationLiu, J.,Kozhaya, L.,Torres, V.J.,Unutmaz, D.,Lu, M.
Structure-based discovery of a small-molecule inhibitor of methicillin-resistantStaphylococcus aureusvirulence.
J.Biol.Chem., 295:5944-5959, 2020
Cited by
PubMed Abstract: The rapid emergence and dissemination of methicillin-resistant (MRSA) strains poses a major threat to public health. MRSA possesses an arsenal of secreted host-damaging virulence factors that mediate pathogenicity and blunt immune defenses. Panton-Valentine leukocidin (PVL) and α-toxin are exotoxins that create lytic pores in the host cell membrane. They are recognized as being important for the development of invasive MRSA infections and are thus potential targets for antivirulence therapies. Here, we report the high-resolution X-ray crystal structures of both PVL and α-toxin in their soluble, monomeric, and oligomeric membrane-inserted pore states in complex with -tetradecylphosphocholine (CPC). The structures revealed two evolutionarily conserved phosphatidylcholine-binding mechanisms and their roles in modulating host cell attachment, oligomer assembly, and membrane perforation. Moreover, we demonstrate that the soluble CPC compound protects primary human immune cells against cytolysis by PVL and α-toxin and hence may serve as the basis for the development of an antivirulence agent for managing MRSA infections.
PubMed: 32179646
DOI: 10.1074/jbc.RA120.012697
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.35 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon